Termination of trial of streptokinase in severe acute ischaemic stroke. MAST Study Group

Can restoring tidal wetlands reduce estuarine nuisance flooding of coasts under future sea-level rise?

Earth's future·2025

Validation of a scanning technique with minimal compression for measuring muscle volume with freehand 3D ultrasound.

Journal of biomechanics·2023

Acute stroke care in France: Survey in the 138 stroke units.

Revue neurologique·2022

Spinal infarcts.

Revue neurologique·2021

The first case of traumatic internal carotid arterial dissection? Verneuil's case report from 1872.

Revue neurologique·2020

EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke.

European journal of neurology·2020

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lancet (London, England)·2026

Characterization of Erythropoiesis and Iron Metabolism in Young Patients With Hereditary Pyropoikilocytosis: A Multicenter Study From Thailand.

Pediatric blood & cancer·2026

Association of Butylphthalide Combined with Antiplatelet Therapy with Functional Recovery After Intravenous Thrombolysis in Acute Ischemic Stroke.

Journal of visualized experiments : JoVE·2026

Clonal Hematopoiesis of Indeterminate Potential and Bone Mineral Density in Cohorts from Trans-Omics for Precision Medicine.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026

Takayasu Arteritis Presenting With Hypotension and Chronic Cerebral Infarctions in a Young Woman: A Case Report.

Cureus·2026

Hypothermic fibrillatory arrest may not increase stroke risk in minimally invasive mitral valve surgery: A 13-year propensity score-matched experience.

JTCVS open·2026

Retraction notice to "The Prognostic-Diagnostic paradox of lead aVR: from 'STEMI-Equivalent' to 'High-Risk NOMI' in the era of precision cardiology" [IJC Heart Vasc. 63 (2026) 101893].

International journal of cardiology. Heart & vasculature·2026

Related Experiment Videos

Termination of trial of streptokinase in severe acute ischaemic stroke. MAST Study Group

Related Concept Videos

Can restoring tidal wetlands reduce estuarine nuisance flooding of coasts under future sea-level rise?

Validation of a scanning technique with minimal compression for measuring muscle volume with freehand 3D ultrasound.

Acute stroke care in France: Survey in the 138 stroke units.

Spinal infarcts.

The first case of traumatic internal carotid arterial dissection? Verneuil's case report from 1872.

EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Characterization of Erythropoiesis and Iron Metabolism in Young Patients With Hereditary Pyropoikilocytosis: A Multicenter Study From Thailand.

Association of Butylphthalide Combined with Antiplatelet Therapy with Functional Recovery After Intravenous Thrombolysis in Acute Ischemic Stroke.

Clonal Hematopoiesis of Indeterminate Potential and Bone Mineral Density in Cohorts from Trans-Omics for Precision Medicine.

Takayasu Arteritis Presenting With Hypotension and Chronic Cerebral Infarctions in a Young Woman: A Case Report.

Hypothermic fibrillatory arrest may not increase stroke risk in minimally invasive mitral valve surgery: A 13-year propensity score-matched experience.

Retraction notice to "The Prognostic-Diagnostic paradox of lead aVR: from 'STEMI-Equivalent' to 'High-Risk NOMI' in the era of precision cardiology" [IJC Heart Vasc. 63 (2026) 101893].

Related Experiment Videos

Termination of trial of streptokinase in severe acute ischaemic stroke. MAST Study Group

Related Concept Videos

Related Articles